<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cuadrado</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kügler</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lastres-Becker</surname>
    <given-names>I.</given-names>
   </name>
  </person-group> (
  <year>2018</year>). 
  <article-title>Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy</article-title>. 
  <source>Redox Biol.</source>
  <volume>14</volume>, 
  <fpage>522</fpage>–
  <lpage>534</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.redox.2017.10.010</pub-id>
  <pub-id pub-id-type="pmid">29121589</pub-id>
 </mixed-citation>
</ref>
